Phico Therapeutics raises £7m to advance next-gen antibiotic candidate
Funds will support continued development of company’s SASPject platform and progression of lead product PT3.9
Read More
Tag: antibiotic
MHRA approves Polyphor’s phase 1 trial of novel inhaled antibiotic
Murepavadin is being developed to treat Pseudomonas aeruginosa infections in people with cystic fibrosis
Read More
Novel antibiotic Recarbrio has launched in the UK
Combination treatment scored EU approval earlier this year
Read More
New AI-created antibiotic can kill many antibiotic-resistant bacteria
The AI system can screen more than a hundred million chemical compounds in a matter of days.
Read More
NICE recommends antiseptics over antibiotics for impetigo
Antiseptic such as hydrogen peroxide 1% cream is ‘just as effective’ as a topical antibiotic.
Read More
MSD to file antibiotic Zerbaxa for pneumonia
MSD is gearing up to file antibiotic Zerbaxa on both sides of the Atlantic for certain forms of pneumonia on the success of a late-stage trial backing its safety and efficacy.
Read More
Motif Bio’s antibiotic granted US priority review
US regulators have accepted for review a targeted, Gram-positive investigational antibiotic developed by UK biopharma Motif Bio for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
Read More
Tetraphase stock plummets on antibiotic failure
Tetraphase Pharmaceuticals saw its stock plummet after revealing that a Phase III study of its experimental antibiotic eravacycline missed key targets in a late stage trial.
Read More
US clears new antibiotic for UTIs
The US Food and Drug Administration has approved a new antibacterial drug to treat patients with complicated urinary tract infections (UTI).
Read More
US regulatory panel backs Cempra’s new antibiotic
Advisors to the US Food and Drug Administration have narrowly backed approval of Cempra’s new antibiotic solithromycin as a treatment for community acquired bacterial pneumonia (CABP).
Read More
Study data back efficacy of AZ novel antibiotic
A late-stage study has confirmed the efficacy of AstraZeneca’s new combination antibiotic Zavicefta in patients with hospital acquired pneumonia (HAP), including ventilator associated pneumonia (VAP).
Read More
EU clears AstraZeneca’s new antibiotic
AstraZeneca’s Zavicefta has been approved for use in the European Union to treat patients with serious Gram-negative bacterial infections requiring hospitalisation.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
